Blog
Provocholine®
Aridol®
Partnerships
Training
Clinical Research Consultation
CRCE Courses
Blogs / Podcast
Guidelines / Publications
Speaking Engagements
Welcome to Our Blog
Methapharm Respiratory is proud to work with healthcare practitioners to support the right diagnosis for patients exhibiting common respiratory symptoms such as cough, wheeze, and shortness of breath. We are a trusted partner for bronchoprovocation testing, supplying Provocholine and Aridol. We also offer training and education (CRCE) at no cost.
This blog is intended to be an additional resource to the education Methapharm currently offers through the American Association for Respiratory Care (AARC) and the Canadian Society of Respiratory Therapists (CSRT) approved CRCEs. While this blog will not provide education credits, it will explore current issues and interesting topics relevant to readers’ day-to-day work and personal lives. We hope that you will investigate further any of the topics we cover here. Please join us monthly as we share respiratory-related topics and beyond.
COPD & Emphysema
Emphysema is a chronic progressive disease of the airways, specifically the alveoli. Emphysema is the destruction and enlargement of the alveoli. The alveoli are the air sacks located at the ends of the bronchioles (alveolus is the singular or one air sac). The number...
Recent Posts
Asthma Peak Week
Summer is rapidly coming to a close. Children, and parents, are preparing to return to school. There is the excitement of shoe shopping, buying supplies, learning who their teacher will be, getting their class schedule and new books. As school resumes and the...
Fractional Exhaled Nitric Oxide (FeNO) in Clinical Practice
Fractional Exhaled Nitric Oxide (FeNO) testing has emerged as a valuable tool in both the diagnosis and management of asthma. It is a non-invasive, quick, and easy test that measures the concentration of nitric oxide in exhaled breath. This helps provide insights...
Test Before Diagnosing
262 million people world-wide have asthma. Twenty-five million Americans have asthma. Ten people die each day in the United States from an asthma exacerbation. It is a heterogenous disease that can be difficult to diagnose and manage. There are objective tests...